Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis

Journal of Clinical Investigation

Volumn 90, Issue 5, 1992, Pages 1718-1725

  Shultz, Pamela J ^a,b   Raij, Leopoldo ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cortical necrosis; Cyclic 3 ,5 guanosine monophosphate; Fibrin; Nitrate; Nitrite

Indexed keywords

ARGININE; ARGININE METHYL ESTER; CYCLIC GMP; ESCHERICHIA COLI ENDOTOXIN; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; GLOMERULUS; KIDNEY; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOSIS;

ANIMAL; ARGININE; BLOOD PRESSURE; CYCLIC GMP; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, NON-P.H.S.; THROMBOSIS;

EID: 0026443619     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116045     Document Type: Article

References (36)

1. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-469.
2. Beller, F. K. 1969. The role of endotoxin in disseminated intravascular coagulation. Thromb. Diath. Haemorrh. 36:125-149.
3. Raij, L., W. F. Keane, and A. F. Michael. 1977. Unilateral Shwartzman reaction: cortical necrosis in one kidney following in vivo perfusion with endotoxin. Kidney Int. 12:91-95.
4. Gaynor, E., C. A. DeBouvier, and T. H. Spaet. 1970. Vascular lesions: possible pathogenic basis of the generalized Shwartzman reaction. Science (Wash. DC). 170:986-988.
5. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
6. Ignarro, L. J., and P. J. Kadowitz. 1985. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25:171-191.
7. Radomski, M., R. M. J. Palmer, and S. Moncada. 1987. A comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92:181-197.
8. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1987. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148:1482-1489.
9. Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 27:8706-8711.
10. Beasley, D., J. H. Schwartz, and B. M. Brenner. 1991. Interleukin 1 induces prolonged L-arginine dependent cyclic guanosine monophosphate and nitric production in rat vascular smooth muscle cells. J. Clin. Invest. 87:602-608.
11. Shultz, P. J., M. A. Tayeh, M. A. Marietta, and L. Raij. 1991. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J. Physiol. 261:F600-F606.
12. Knowles, R. G., M. Salter, S. L. Brooks, and S. Moncada. 1990. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172:1042-1048.
13. G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 87:3629-3632.
14. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
15. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1557-1558.
16. Raij, L., S. Azar, and W. Keane. 1984. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26:137-143.
17. Shultz, P. J., A. E. Schorer, and L. Raij. 1990. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am. J. Physiol. 258:F162-F167.
18. Bartholomew, B. 1984. A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. Food Chem. Toxicol. 22:541-543.
19. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin. Invest. 85:264-273.
20. 15N nitrate in biological fluids. Anal. Biochem. 126:131-138.
21. Tolins, J. P., and L. Raij. 1991. Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension (Dallas). 17:1045-1051.
22. Stuehr, D. J., and M. A. Marletta. 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82:7738-7742.
23. Hibbs, J. B., Jr., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R. L. Baranowski, J. H. Ward, R. L. Menlove, M. P. McMurry, J. P. Kushner, et al. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89:867-877.
24. Tolins, J. P., R. M. J. Palmer, S. Moncada, and L. Raij. 1990. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258:H655-H662.
25. Nathan, C. F., and D. J. Stuehr. 1990. Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension? J. Natl. Cancer Inst. (Bethesda). 82:762-772.
26. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
27. Lamas, S., T. Michel, B. M. Brenner, and P. A. Marsden. 1991. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-a. Am. J Physiol. 261:C634-C641.
28. Bergstein, J. M., J. R. Hoyer, and A. F. Michael. 1974. Glomerular fibrinolytic activity following endotoxin-induced glomerular fibrin deposition in the pregnant rat. Am. J Pathol. 75:195-202.
29. Ferrario, R., A. Fogo, K. Takahashi, and K. F. Badr. 1991. Microcirculatory responses to inhibition of nitric oxide (NO) synthesis in normal kidneys and during acute glomerulonephritis in the rat. J. Am. Soc. Nephrol. 2:504. (Abstr.)
30. GC) and proteinuria: chronic blockade of endogenous endothelial derived relaxing factor (EDRF). J. Am. Soc. Nephrol. 2:471. (Abstr.)
31. Shultz, P. J., J. P. Tolins, and L. Raij. 1990. Endothelial-derived vasoactive substances and the kidney. Kidney. 23:1-8.
32. Luscher, T. F., and P. M. Vanhoutte. 1988. Hypertension and endothelium-dependent responses. In Vasodilatation-Vascular Smooth Muscle, Peptides, Autononic Nerves, and Endothelium. P. M. Vanhoutte, editor. Raven Press Ltd., New York. 523-529.
33. G-Monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J. Leukocyte Biol. 48:565-569.
34. Donohoe, J. F. 1983. Acute bilateral cortical necrosis. In Acute Renal Failure. B. J. Brenner, J. M. Lazarus, editors. W. B. Saunders Co., Philadelphia. 252-268.
35. Editorial. 1991. Nitric oxide in the clinical arena. Lancet. 338:1560-1562.
36. Nava, E., R. M. J. Palmer, and S. Moncada. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 338:1555-1557.